GLIS2 and tumor of parathyroid gland: The deregulated expression of specific lncRNAs (lncRNA PVT1, lncRNA GLIS2-SA1, and lncRNA BC200) also appears to characterize molecular signatures of human PCs, distinguishing between benign and malignant parathyroid tumors.